-
Obesity is gaining ground in the United States. Are you prepared to offer women effective options? James Trussell, PhD, professor of economics and public affairs and director of the Office of Population Research at Princeton (NJ) University, reviewed current research at the 2007 Contraceptive Technology conferences to help clinicians select appropriate options.
-
The next patient in your exam room is a 23-year-old woman who is experiencing her third episode of symptomatic bacterial vaginosis (BV) in six months. Which of the following strategies would you recommend?
-
Results of a large national study of young men and women ages 18-27 suggest that Mycoplasma genitalium, a relatively new sexually transmitted infection, surpassed gonorrhea in prevalence.
-
Robert Hatcher, MD, MPH, professor of obstetrics and gynecology at Atlanta's Emory University and chairman of the editorial board for Contraceptive Technology Update, is the 2007 recipient of the Kenneth J. Ryan, MD, Physician Leadership Award.
-
Although the addition of PCI to optimal medical therapy in patients with chronic stable CHD reduced the prevalence of angina, it did not reduce the long-term rates of death, nonfatal myocardial infarctions and hospitalizations for acute coronary syndromes.
-
The FDA has approved the first of a new class of antibiotics for the topical treatment of impetigo. Retapamulin belongs to a class of agents called pleuromutilins.
-
Unless prophylaxed, most post-stroke patients with hemiplegia develop deep venous thrombosis (DVT), and as many as 20% sustain pulmonary embolism (PE).
-
A randomized controlled trial of 281 men with BPH showed that once daily Tadalafil (Cialis) 20 mg improved lower urinary tract symptoms compared with placebo.
-
A prediction tool that factors age, history of smoking, BMI, and alcohol use can determine a man's risk for colorectal cancer.
-
The new guidelines recommend antibiotic prophylaxis of infective endocarditis in a much more restricted group of patients than did previous guidelines.
